3 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp08354 | Seq ID No. 16 from patent ID US202000079827A1 | LKKWWKKVKGLLGGLLGKVKSVIK | Synthetic | Not Available | Tetrazolium-based assay | HOP-062 | Lung Cancer | Cell viability > 50% at 20 μM |
| dbacp08355 | Seq ID No. 16 from patent ID US202000079827A1 | LKKWWKKVKGLLGGLLGKVKSVIK | Synthetic | Not Available | Tetrazolium-based assay | NCI-H460 | Lung Cancer | Cell viability > 50% at 20 μM |
| dbacp08356 | Seq ID No. 16 from patent ID US202000079827A1 | LKKWWKKVKGLLGGLLGKVKSVIK | Synthetic | Not Available | Tetrazolium-based assay | Calu-1 | Lung Cancer | Cell viability > 50% at 20 μM |